HEALTH CARE MIDDLE EAST AND NORTH AFRICA Innovation powering health care delivery

Size: px

Start display at page:

Download "HEALTH CARE MIDDLE EAST AND NORTH AFRICA Innovation powering health care delivery"

Benedict Marshall
6 years ago
Views:

1 #hcmena HEALTH CARE MIDDLE EAST AND NORTH AFRICA Innovation powering health care delivery OCTOBER 13TH 2015 MADINAT JUMEIRAH, MINA A SALAM, DUBAI Explore a tangible roadmap towards achieving a truly world-class health care system in the Middle East and North Africa GOLD SPONSORS Research Based Pharmaceutical Companies Committee in Saudi

2 ABOUT THE SUMMIT How can the Middle East and North Africa deliver a truly world-class health-care system? The MENA region has faced a surge in demand for health care services in recent years. Shifting socio-economic factors such as increased income and better access to modern amenities have led to widespread lifestyle changes, fuelling a rise in lifestyle-related illnesses such as cancer, obesity, diabetes and heart disease. According to the World Health Organisation (WHO), non-communicable diseases will account for nearly 60% of the region s disease burden in the next five years. The International Diabetes Federation (IDF) estimates that one in 10 adults in the Middle East region currently suffers from diabetes. It forecasts that this figure will more than double over the next twenty years, reaching 68 million, or 25% of the estimated population by HEALTH CARE MIDDLE EAST SUMMIT 2014 STATISTICS 182 attendees Join us as we bring together decision makers from the public and private sectors to explore how can the Middle East & North Africa deliver a truly world-class health care system: Hear from national and international policy makers representing the World Health Organisation, Ministry of Education Bahrain, International Diabetes Federation and the Saudi Commission for Health Specialties. Gain new perspectives on the future of health-care systems in the region; discuss policy, trends, tackling the talent crisis, international benchmarking and technological innovation. Network with influential health-care stakeholders that include government, pharmaceutical, biotech, healthcare providers, suppliers, patient groups and NGOs. Group discounts are available for groups of 3 or more delegates. Please the team on emeaevents@economist.com or call +44 (0) for further details 62% of the audience were director level or above 100% of our audience would recommend our event to colleagues SUPPORTING PUBLICATIONS SUPPORTING ORGANISATION SUPPORTED BY 17 countries represented

PROGRAMME Tuesday October 13th 2015 09.30 OPENING REMARKS FROM THE CHAIR Dr Vivek Muthu, Chair, Economist Intelligence Unit Healthcare, United Kingdom 09.

15 KEYNOTE ADDRESS: HIGHLIGHTING THE UAE S COMMITMENT TO DRIVING GROWTH AND COMPETITIVENESS IN THE HEALTH CARE SECTOR 10.

3 PROGRAMME Tuesday October 13th OPENING REMARKS FROM THE CHAIR Dr Vivek Muthu, Chair, Economist Intelligence Unit Healthcare, United Kingdom KEYNOTE ADDRESS: INNOVATION, EFFICIENCY AND EFFECTIVENESS IN DELIVERING A HIGH QUALITY, SUSTAINABLE HEALTH CARE ECOSYSTEM KEYNOTE ADDRESS: HIGHLIGHTING THE UAE S COMMITMENT TO DRIVING GROWTH AND COMPETITIVENESS IN THE HEALTH CARE SECTOR PANEL DISCUSSION: HEALTH CARE POLICY AND THE ROLE OF INDUSTRY: ALIGNING PUBLIC AND PRIVATE SECTOR OBJECTIVES TO DRIVE INNOVATION IN HEALTH CARE DELIVERY According to WHO statistics, the GCC has one of the highest incidences of NCDs in the world. A vast youth demographic and a rapidly ageing population, paired with vast socio-economic disparity across the region resulting in varying rates of access to health care facilities and treatments, regional governments are facing significant challenges to ensure health systems are robust, sustainable and provide quality, affordable care to all. The GCC pricing harmonisation policy, enacted throughout 2014, has been a strategic attempt to regulate pricing and improve access to medicines. However, there is debate around the efficacy of this policy many argue that price restrictions are hindering innovation and ultimately, adversely affecting patient health as well as sector growth. This session will bring together key stakeholders from government and the private sector to talk about the strategic policies guiding the future of health care in the region, identifying the main challenges to implementation, and what tangible KPIs need to be put in place to ensure a collaborative approach to foster innovation and deliver world-class health care throughout the Middle East. Marwan Abdulaziz Executive Director, DuBiotech, Petra Wilson,, International Diabetes Federation, Belgium Sameen Siddiqi, Director, Department of Health Systems Development, Eastern Mediterranean Regional Office, World Health Organization, Egypt Samir A. Khalil, Executive Director, Middle East & Africa Pharmaceutical Research and Manufacturers of America (PhRMA) MORNING REFRESHMENTS AND NETWORKING BREAK PANEL DISCUSSION: EVOLVING HEALTH CARE TRENDS: IMPROVING ACCESSIBILITY, EFFICIENCY AND EFFECTIVENESS This session will provide a platform for discussion around evolving health care trends across the MENA region, including feedback on initiatives empowering primary care physicians and the growing scope of primary care centres. It will examine the role of community-centred care and accessible cities outpatient facilities for more efficient, and accessible, treatment options for chronic illnesses, rehabilitative care, geriatric as well as examine the issue of patient accountability. It will also evaluate regional initiatives to improve affordability and access to care such as compulsory insurance regulations, providing feedback on how these programmes are rolling out and lessons learned from a year in review as well as a discussion around how innovation is improving efficiency and effectiveness in health care delivery. A Abyad,, Abyad Medical Center; Chairman, Middle East Academy for Medicine of Aging; Coordinator, Middle East Network on Aging; Editor, Middle East Journal of Family Medicine, Lebanon Benjamin Frank,, Sheikh Khalifa Medical City, David Hadley,, Mediclinic Middle East, Hisham Radwan, VP, Regional General Manager MEA, Aetna International, Salma al-jaouni,, Health Care Accreditation Council, Jordan Excellently planned and managed event. Managing Director DNA Health Corp

This session will provide a model demonstrating the link between health care investment in R&D, skills training, manufacturing and innovation resulting in Singapore s current position as a

4 13.00 INTERNATIONAL BENCHMARKING: HOW IS SINGAPORE DRIVING INNOVATION AND VALUE-GENERATION IN BIOMEDICAL R&D? Over the past twenty years, Singapore has made a concerted effort to establish itself as a global leader in biomedical R&D. This session will provide a model demonstrating the link between health care investment in R&D, skills training, manufacturing and innovation resulting in Singapore s current position as a world-leading health care hub. Benjamin Seet, Executive Director, Biomedical Research Council, A*Star, Singapore LUNCH TACKLING THE TALENT CRISIS: EDUCATION AND SKILLS TRAINING FOR A SUSTAINABLE HEALTH CARE SYSTEM The Middle East is facing a severe shortage of skilled medical talent. With the major push to increase capacity in recent years leading to an ever-growing number of health care facilities, and increased demand from a growing population burdened with high rates of NCDs, the pressure is on to source qualified medical professionals. In the GCC, it is estimated that over 80% of physicians and nurses are expats. Authorities are faced with the task of encouraging MENA nationals to take roles in the burgeoning health care sector, whilst also ensuring the educational framework is in place to support further skills development. This session will explore what is being done to address the talent shortage in the health care sector and what measures need to be put in place to ensure a sustainable resource infrastructure going forward. Abdulaziz H Al Saigh, Secretary General, Saudi Commission for Health Specialties, Saudi Arabia Cameron Mirza, Head of Projects and Strategy, Secretariat-General of the Higher Education Council, Ministry of Education, Bahrain Dr Javaid I Sheikh, Dean, Weill Cornell Medical College in Qatar; Co-Chair, Executive Committee of Qatar Academic Health System; Board of Directors, Sidra Medical and Research Center, Qatar PANEL DISCUSSION: TECHNOLOGICAL INNOVATION AND QUALITY OF CARE Patient safety, resource efficiency, affordability and accessibility are all key considerations when evaluating quality of care outcomes. Advancements in medical technologies and ICT mean that health care systems and providers are better able to treat and care for patients, with the added benefit of improving efficiencies and reducing costs. This session will delve into the role of innovation in how we collect, manage and analyse patient data, as well as evaluate the latest technological innovations allowing for more affordable, higher quality care in the MENA region. Bern Shen, Chief Medical Officer, HealthCrowd; Board Member, TechWadi, Gareth Sherlock, Chief Information Officer, Cleveland Clinic, Abu Dhabi CLOSING KEYNOTE: THE FUTURE OF HEALTH CARE: FOCUS ON THE PATIENT EXPERIENCE Hear from this world-leader in health care on the trends and innovations that are best serving patients. David Hayes, Medical Director, Mayo Clinic, United States CLOSING REMARKS AND END OF CONFERENCE It brought stakeholders from all walks of life/ business together Director UNAIDS

CONFIRMED SPEAKERS INCLUDE: A ABYAD, Abyad Medical Center; Chairman, Middle East Academy for Medicine of Aging; Coordinator Middle East Network on Aging; Editor Middle East Journal of Family Medicine

MARWAN ABDULAZIZ Executive Director DuBiotech DAVID HADLEY Mediclinic Middle East DAVID HAYES Medical Director Mayo Clinic United States Samir A.

Council Ministry of Education Bahrain HISHAM RADWAN, VP, Regional General Manager MEA Aetna International BERN SHEN Chief Medical Officer, HealthCrowd; Board Member TechWadi BENJAMIN SEET Executive

5 CONFIRMED SPEAKERS INCLUDE: A ABYAD, Abyad Medical Center; Chairman, Middle East Academy for Medicine of Aging; Coordinator Middle East Network on Aging; Editor Middle East Journal of Family Medicine Lebanon SALMA AL-JAOUNI Health Care Accreditation Council Jordan ABDULAZIZ H AL-SAIGH Secretary General Saudi Commission for Health Specialties Saudi Arabia BENJAMIN FRANK Sheikh Khalifa Medical City MARWAN ABDULAZIZ Executive Director DuBiotech DAVID HADLEY Mediclinic Middle East DAVID HAYES Medical Director Mayo Clinic United States Samir A. Khalil, Executive Director, Middle East & Africa Pharmaceutical Research and Manufacturers of America (PhRMA) CAMERON MIRZA Head of Projects and Strategy, Secretariat-General of the Higher Education Council Ministry of Education Bahrain HISHAM RADWAN, VP, Regional General Manager MEA Aetna International BERN SHEN Chief Medical Officer, HealthCrowd; Board Member TechWadi BENJAMIN SEET Executive Director Biomedical Research Council A*Star Singapore SAMEEN SIDDIQI Director, Department of Health Systems Development, Eastern Mediterranean Regional Office World Health Organization Egypt JAVAID I SHEIKH Dean, Weill Cornell Medical College in Qatar; Co-Chair, Executive Committee of Qatar Academic Health System; Board of Directors, Sidra Medical and Research Center Qatar PETRA WILSON International Diabetes Federation Belgium Sponsorship opportunities are available. Please contact Kay Westmoreland on or kaywestmoreland@economist.com.

2014 ATTENDING COMPANIES INCLUDED: 7 Days Abbott Laboratories AbbVie BioPharmaceuticals GmBH ABC Dubai Abu Dhabi National Insurance Company Aegis Capital Aetna Al Mariya Polyclinic Al Noor Hospital

Batterjee Holding Company Bayer Healthcare Bennett Jones BeUtiful You BLI Boehringer Ingelheim Bristol-Myers Squibb Burjeel Hospital CAIN ClinArt International Clinart MENA Dar Al Khaleej DNA Health

8 Dubai Health Authority DuBiotech Economist Intelligence Unit Edelman Eli Lilly and Company Emmahim Global Network Link Falcon and Associates GE Healthcare Grayling GSK Gulf News Health Authority of

6 2014 ATTENDING COMPANIES INCLUDED: 7 Days Abbott Laboratories AbbVie BioPharmaceuticals GmBH ABC Dubai Abu Dhabi National Insurance Company Aegis Capital Aetna Al Mariya Polyclinic Al Noor Hospital AlSharq Health Care Member of Fujairah National Group American Hospital Anglo Arabian Healthcare Arya Insurance Brokerage Company AstraZeneca Atlas Medical Technologies Axa Insurance Bait Al Batterjee Holding Company Bayer Healthcare Bennett Jones BeUtiful You BLI Boehringer Ingelheim Bristol-Myers Squibb Burjeel Hospital CAIN ClinArt International Clinart MENA Dar Al Khaleej DNA Health Corp Dubai Eye Dubai Health Authority DuBiotech Economist Intelligence Unit Edelman Eli Lilly and Company Emmahim Global Network Link Falcon and Associates GE Healthcare Grayling GSK Gulf News Health Authority of Abu Dhabi Health Beyond Borders Healthcare Industry Service Center Hoffmann-La Roche Ltd ICME International Janssen Gulf Johns Hopkins Aramco Healthcare Joint Commission International Julphar KARL STORZ - ENDOSKOPE East Mediterranean Gulf King Hussein Cancer Foundation King Saud bin Abdulaziz University Kleos Healthcare Corporation Kuwait News Agency (KUNA) Leo Pharma Les Laboratoires Servier - Gulf Region Lux Actuaries and Consultants Mafraq Hospital- SEHA Manchester Clinic Jumeriah MD Lifeline Hospital MedDrop GmbH Mediclinic City Hospital Dubai MEED Menasa and Partners Merck Sharp & Dohme Middle East Health Magazine Moorland Gray Executive Search Mundipharma NGC Medical NMC Healthcare Novartis Now Health International Oracle Middle East and North Africa Pfizer Pharmax Pharmaceuticals FZ Philips PhRMAG Prime Minister s Office, UAE Quanteus RAK Hospital Sanofi Saudi Aramco Shane Phillips Consultants Sheikh Khalifa Medical City Siegel+Gale Spengler Fox Supreme Council of Health Taha Actuaries & Consultants Takeda Tawam Hospital TECOM Investments The Gulf Today The National Thomson Reuters U N CARGO & LOGISTIC Vision Executive Search vps healthcare

7 HEALTH CARE MIDDLE EAST AND NORTH AFRICA October 13th Madinat Jumeirah, Mina A Salam Hotel, Dubai, UAE DELEGATE FEES (PER PERSON) Category Standard Rate Quantity Total Pharmaceutical & Biotech Companies $ Health Care Providers $ Subscribers to The Economist $ Gov/NGOs/public sector $ Discounts are available for groups of 3 or more delegates. Please the team on emeaevents@economist.com or call +44 (0) for further details DELEGATE DETAILS First Name (Dr/Mr/Mrs/Ms) Job Title Surname Industry Sector Company Address Town/city Postcode Country Tel Fax Payment methods (delegates fee(s) strictly payable in advance) Credit Card (tick as appropriate): Amex Visa Mastercard Name as it appears on card: Card No. Expiry date: / 3/4 digital security number: Bank transfer Payable to Barclays Bank Plc, please quote ref: EM1342 and send a copy of the instructions together with your registration form. Account Name: The Economist Intelligence Unit. Account Number: , Sort Code: IBAN: GB09BARC Swift address: BARCGB22 We require an invoice to raise payment (Bookings with requests for bank tranfsers and invoices should be received before September 12th 2015.) Please complete below if the billing contact is not the registered delegate. Billing contact: PO number (if required): Billing address (if different from the Organisation address): Total HOW TO REGISTER ONLINE emeaevents@economist.com CALL US +44 (0) FAX +44 (0) POST The Economist Events, Customer Service EMEA, 20 Cabot Square, Canary Wharf, London E14 4QW, UK DATA PROTECTION The Economist Events is part of The Economist Group. Occasionally, the companies in The Economist Group would like to contact you about new features, events, news, special offers and for market research purposes. Tick this box if you d like to hear from us by We ll assume that we may contact you unless you tick these boxes: No contact from us by post No contact from us by telephone No contact from other selected companies about their products and services by post The Economist Group is a global organisation and operates a strict privacy policy around the world. To read more about us and our privacy policy please go to TERMS AND CONDITIONS Your delegate fee should be paid in full prior to attendance. If payment has not been received you will not be permitted to enter the event. Cancellations: Should you not be able to attend the event, substitutions can be made at no extra charge up until the event. If a suitable replacement cannot be found, then an administration fee of 20% will be incurred for cancellations received more than 21 days prior to an event. When a cancellation is made less than 21 days prior to an event, the registered delegate is liable for full payment of the fee. Economist Events reserve the right to change the programme if necessary. CONFIRMATION I confirm that I have read and accepted The Economist Events terms and conditions policy and I am authorised to sign this document on behalf of the above company. Signature: Date:

HEALTH CARE MIDDLE EAST AND NORTH AFRICA Innovation powering health care delivery

www.hcmena.economist.com @EconomistEvents #hcmena HEALTH CARE MIDDLE EAST AND NORTH AFRICA Innovation powering health care delivery OCTOBER 13TH 2015 MADINAT JUMEIRAH, MINA A SALAM, DUBAI Explore a tangible